Pharmacologic induction of CD8+ T cell memory: better living through chemistry

Sci Transl Med. 2009 Dec 16;1(11):11ps12. doi: 10.1126/scitranslmed.3000302.

Abstract

The generation of a robust population of memory T cells is critical for effective vaccine and cell-based therapies to prevent and treat infectious diseases and cancer. A series of recent papers have established a new, cell-intrinsic approach in which small molecules target key metabolic and developmental pathways to enhance the formation and maintenance of highly functional CD8(+) memory T cells. These findings raise the exciting new possibility of using small molecules, many of which are already approved for human use, for the pharmacologic induction of immunologic memory.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • CD8-Positive T-Lymphocytes* / drug effects
  • CD8-Positive T-Lymphocytes* / immunology
  • Cancer Vaccines / chemistry
  • Cancer Vaccines / immunology
  • Humans
  • Immunologic Memory* / drug effects
  • Immunologic Memory* / immunology
  • Immunosuppressive Agents / chemistry
  • Immunosuppressive Agents / immunology
  • Immunosuppressive Agents / therapeutic use
  • Intracellular Signaling Peptides and Proteins / immunology
  • Protein Serine-Threonine Kinases / immunology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Sirolimus / chemistry
  • Sirolimus / immunology
  • Sirolimus / therapeutic use
  • T-Lymphocyte Subsets* / drug effects
  • T-Lymphocyte Subsets* / immunology
  • TOR Serine-Threonine Kinases

Substances

  • Cancer Vaccines
  • Immunosuppressive Agents
  • Intracellular Signaling Peptides and Proteins
  • MTOR protein, human
  • Protein Serine-Threonine Kinases
  • TOR Serine-Threonine Kinases
  • Sirolimus